Transdiagnostic Research Program (TRP)

The Transdiagnostic Research Program (TRP) is dedicated to understanding cognitive mechanisms that underlie the maintenance of depression, anxiety, and eating symptomatology in  multiple sclerosis, endometriosis, clinical and community populations. The information from this research program will be used to develop effective psychological interventions targeting these populations.

Collected data will be used to contribute toward significant academic research by research students and staff within the Melbourne School of Psychological Sciences, The University of Melbourne.

We are currently recruiting for this research program and your contribution would be highly valued. Please proceed to the 'participation' tab for more information.


Research has consistently revealed that high levels of depression and anxiety are prevalent among individuals diagnosed with multiple sclerosis, endometriosis and eating disorders. Moreover, depression and anxiety are the most frequently comorbid to with each other, and such comorbidity is associated with greater distress, functional impairment, and risk of suicide. Such findings show the complexity of comorbidity within medically unwell and clinical populations, thus accentuating the significance of addressing this comorbidity.
However, current approaches for treating anxiety, depression and eating disorders are characterised by disorder specific treatments, most commonly under the forms of cognitive-behavioural therapy (CBT). Whilst disorder specific treatments have a strong evidence-base, there has been an increase in attention in utilising transdiagnostic approaches which focus on identifying and treating common cognitive and behavioural mechanisms underlying the maintenance of multiple disorders. Having insight into such transdiagnostic factors can help us to potentially identify ways to target specific mechanisms that may contribute to poorer adaptation following the diagnosis or treatment for a medical condition, as well as help target the complex clinical presentations characterised by substantial comorbidity commonly evident in treatment settings. Further understanding of the transdiagnostic factors associated with anxiety, depression, and eating disorders will assist in developing effective psychological interventions for individuals including those that have multiple sclerosis, endometriosis and clinical populations.

What are the requirements for participation?

18 years and above
Sufficient command of English Language

How can I participate?

Please complete  questionnaire one by following this link - (QL)

We will ask you to complete the questionnaire at three different timepoints. After completing the first questionnaire you will be sent an automatic survey link at a 6 month and 12 month timepoint.

We hope to receive your responses to this questionnaire at three different time points
Once you complete all three questionnaires, you will be entered into a draw to receive an e-gift prize.

Your responses at these three time points are greatly appreciated as they allow researchers the opportunity to detect important changes over time in depression and anxiety symptoms.



Q: "I live outside of Australia, can I take part?"
A:  Yes. This study accepts responses worldwide.

Q: "My health practitioner/s suspect a diagnosis of multiple sclerosis and/or endometriosis in my case but this has not been confirmed, am I eligible to participate?"
A: Yes

Q:"I'm under 18, can I participate?"
A:  No, this research requires you to be at least 18years old

Q: "Will I receive any compensation for participating?"
A: If you are completing the follow up questionnaires at the 6 and 12 month periods you will go into a draw for an e-gift voucher.
If you are a REP participant you will obtain two hours worth of university credit through the University of Melbourne's Research Experience Program.

Q:"What does informed consent mean?"
A:Informed consent means that you, as a potential research participant, receive all relevant information in clear and understandable language before you decide if you want to take part. For this research study, before you can participate, you must read the 'plain language statement' and sign the consent form to indicate that you have been given this information, and understand everything involved.

The plain language statement is long, but that is because it is important (and an ethical requirement) that you understand what you are being asked to do, and the risks and benefits. We will talk to you about this information, so do let us know if anything is unclear, and do ask any questions you might have.

Q: "Where will my information be stored and who has access to this?"
A: All information will be stored electronically in password protected databases on restricted-access servers, which sit behind university firewalls. Only those staff and students named on the ethics approval for the project will be given access to this data. All identifying information (e.g., your name, address, date of birth, etc.) will be stored separately to the other information you provide (e.g., questionnaire responses).

Q: "Will the results of this research be published? And if so, will my information be deidentified?"
A: Yes, the results of this research will be published. Any personal information that could identify you will be removed before the results are published.

Q: "Will I receive information about my individual survey results?"
A: No. This project is for research purposes only and we are thus unable to provide individualised results. If you have particular questions or concerns, we recommend you discuss them with your general medical practitioner (GP). If you score highly on the depression and anxiety measures there will be an automated email generated which will notify you of this. This email will also contain contact details of support services you may wish to contact.

Q:"Does it cost anything to participate in this research?"
A: No, there is no cost to you in participating

Contact Us

Principal researcher: Dr Litza Kiropoulos ( [